Silvia Sabbioni

10.6k total citations · 3 hit papers
78 papers, 8.4k citations indexed

About

Silvia Sabbioni is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Silvia Sabbioni has authored 78 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 32 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Silvia Sabbioni's work include MicroRNA in disease regulation (26 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (13 papers). Silvia Sabbioni is often cited by papers focused on MicroRNA in disease regulation (26 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (13 papers). Silvia Sabbioni collaborates with scholars based in Italy, United States and Sudan. Silvia Sabbioni's co-authors include Massimo Negrini, Carlo M. Croce, Manuela Ferracin, Angelo Veronese, George A. Calin, Laura Gramantieri, Chang‐Gong Liu, Francesca Fornari, Anne Rosenberg and Massimo Pedriali and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Silvia Sabbioni

76 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA Gene Expression Deregulation in Human Breast Cancer

2005 3.3k citations Marilena V. Iorio, Manuela Ferracin et al. Cancer Research profile →
Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

2007 670 citations Laura Gramantieri, Manuela Ferracin et al. Cancer Research profile →
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

2008 517 citations Francesca Fornari, Laura Gramantieri et al. profile →

Peers

Countries citing papers authored by Silvia Sabbioni

Since Specialization

Citations

This map shows the geographic impact of Silvia Sabbioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Sabbioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Sabbioni more than expected).

Fields of papers citing papers by Silvia Sabbioni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Sabbioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Sabbioni. The network helps show where Silvia Sabbioni may publish in the future.

Co-authorship network of co-authors of Silvia Sabbioni

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Sabbioni. A scholar is included among the top collaborators of Silvia Sabbioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Sabbioni. Silvia Sabbioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 2026 ·Cell Death Discovery ·Silvia Sabbioni, Paola Guerriero, Ram C. Shankaraiah, (unknown), (unknown), Cristian Bassi, Lucilla D’Abundo, Farzaneh Moshiri, (unknown), (unknown), Laura Astolfi, Laura Gramantieri, Roberta Roncarati, (unknown), (unknown), (unknown), Carlo M. Croce, Massimo Negrini, Elisa Callegari	0
2	Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 2024 ·Scientific Reports ·Lucilla D’Abundo, Cristian Bassi, Elisa Callegari, Farzaneh Moshiri, Paola Guerriero, (unknown), (unknown), Andrea Gardini, Angelo Sangiovanni, Fabio Piscaglia, Silvia Sabbioni, Laura Gramantieri, Massimo Negrini	3
3	Functional profile of oral plaque microbiome: Further insight into the bidirectional relationship between type 2 diabetes and periodontitis 2023 ·Molecular Oral Microbiology ·(unknown), Roberto Fariña, Alberto Carrieri, Anna Simonelli, (unknown), Silvia Sabbioni, Leonardo Trombelli, Chiara Scapoli	14
4	Novel Virus Identification through Metagenomics: A Systematic Review 2022 ·Life ·Cristian Bassi, Paola Guerriero, (unknown), Elisa Callegari, Silvia Sabbioni	21
5	A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing 2021 ·SHILAP Revista de lepidopterología ·Ferdinando Scavizzi, Cristian Bassi, Laura Lupini, Paola Guerriero, Marcello Raspa, Silvia Sabbioni	10
6	Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 2021 ·Frontiers in Cell and Developmental Biology ·Noemi Laprovitera, (unknown), Francesco Gelsomino, Elisa Porcellini, Mattia Riefolo, (unknown), Paola Tononi, (unknown), Silvia Sabbioni, Francesca Fontana, Nicolò Manaresi, Antonia D’Errico, Maria A. Pantaleo, Andrea Ardizzoni, Manuela Ferracin	14
7	Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR 2016 ·Journal of Visualized Experiments ·Manuela Ferracin, (unknown), Laura Lupini, Elena Miotto, Silvia Sabbioni, Massimo Negrini	6
8	Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 2015 ·Biomarker Research ·Alessandra Mangolini, Manuela Ferracin, (unknown), Elena Saccenti, (unknown), Valentina Vultaggio-Poma, Juana María Sanz, Angelina Passaro, Massimo Pedriali, Antonio Frassoldati, Patrizia Querzoli, Silvia Sabbioni, Paolo Carcoforo, Alan B. Hollingsworth, Massimo Negrini	78
9	MicroRNA response to environmental mutagens in liver 2011 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Bahaeldin K. Elamin, Elisa Callegari, Laura Gramantieri, Silvia Sabbioni, Massimo Negrini	20
10	MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality 2009 ·Clinical Cancer Research ·Laura Gramantieri, Francesca Fornari, Manuela Ferracin, Angelo Veronese, Silvia Sabbioni, George A. Calin, Gian Luca Grazi, Carlo M. Croce, Luigi Bolondi, Massimo Negrini	261
11	MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells 2009 ·Cancer Research ·Francesca Fornari, Laura Gramantieri, Catia Giovannini, Angelo Veronese, Manuela Ferracin, Silvia Sabbioni, George A. Calin, Gian Luca Grazi, Carlo M. Croce, Simona Tavolari, Pasquale Chieco, Massimo Negrini, Luigi Bolondi	343
12	MicroRNA involvement in hepatocellular carcinoma 2008 ·Journal of Cellular and Molecular Medicine ·Laura Gramantieri, Francesca Fornari, Elisa Callegari, Silvia Sabbioni, Giovanni Lanza, Carlo M. Croce, Luigi Bolondi, Massimo Negrini	244
13	Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma breakdown → 2007 ·Cancer Research ·Laura Gramantieri, Manuela Ferracin, Francesca Fornari, Angelo Veronese, Silvia Sabbioni, Chang‐Gong Liu, George A. Calin, Catia Giovannini, Eros Ferrazzí, Gian Luca Grazi, Carlo M. Croce, Luigi Bolondi, Massimo Negrini	670
14	BK Virus, JC Virus and Simian Virus 40 Infection in Humans, and Association with Human Tumors 2007 ·Advances in experimental medicine and biology ·Giuseppe Barbanti‐Brodano, Silvia Sabbioni, Fernanda Martini, Massimo Negrini, Alfredo Corallini, Mauro Tognon	58
15	Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 2007 ·Cancer Gene Therapy ·Silvia Sabbioni, Elisa Callegari, Riccardo Spizzo, Angelo Veronese, Giuseppe Altavilla, Alfredo Corallini, M. Negrini	2
16	MicroRNA Gene Expression Deregulation in Human Breast Cancer breakdown → 2005 ·Cancer Research ·Marilena V. Iorio, Manuela Ferracin, Chang‐Gong Liu, Angelo Veronese, Riccardo Spizzo, Silvia Sabbioni, Eros Magri, Massimo Pedriali, Muller Fabbri, Manuela Campiglio, Sylvie Ménard, Juan Palazzo, Anne Rosenberg, Piero Musiani, Stefano Volinia, Italo Nenci, George A. Calin, Patrizia Querzoli, Massimo Negrini, Carlo M. Croce	3320
17	Frequent Aberrant Methylation of the *CDH4* Gene Promoter in Human Colorectal and Gastric Cancer 2004 ·Cancer Research ·Elena Miotto, Silvia Sabbioni, Angelo Veronese, George A. Calin, S. Gullini, A Liboni, Laura Gramantieri, Luigi Bolondi, Eros Ferrazzí, Roberta Gafà, Giovanni Lanza, Massimo Negrini	81
18	Simian virus 40 infection in humans and association with human diseases: results and hypotheses 2004 ·Virology ·Giuseppe Barbanti‐Brodano, Silvia Sabbioni, Fernanda Martini, Massimo Negrini, Alfredo Corallini, Mauro Tognon	90
19	Multigene Methylation Analysis of Gastrointestinal Tumors 2003 ·Molecular Diagnosis ·Silvia Sabbioni, Elena Miotto, Angelo Veronese, (unknown), Laura Gramantieri, Luigi Bolondi, (unknown), (unknown), Giovanni Lanza, (unknown), Eros Ferrazzí, Carlo V. Feo, A Liboni, S. Gullini, Massimo Negrini	34
20	Subchromosomal assignment<footref rid="foot01"><sup>1</sup></footref> of the TSSC1 gene to human chromosome band 11p15.5 near the HBB gene cluster 1998 ·Cytogenetic and Genome Research ·(unknown), Silvia Sabbioni, G. Barbanti‐Brodano, Massimo Negrini	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact